2023: Volume 8, Issue 1
Brief Report P.1-4
Patient perspectives on switching from intravenous to subcutaneous infliximab and vedolizumab in inflammatory bowel disease: Results from a cross-sectional survey.
Author(s): Oldenburg L, Wijnands AM, Oldenburg B
Short Communication P.1-2
Contributing factor in the pathogenesis of barrett's esophagus emptying and gastroesophageal reflux clearance.
Author(s): Amy Richter
Perspective P.1-2
Treatment of primary esophageal motility disorders and absence of esophageal peristalsis and failure of the lower esophageal sphincter.
Author(s): Kenro Mariko
Mini Review P.1-2
Autoimmune illness and chronic gastritis caused by helicobacter enteric bacteria.
Author(s): Aimi Jhon
Opinion Article P.1-2
Epigastria hiatus hernia and gastroesophageal reflux disease.
Author(s): Jhon Sophia